The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Immune Cell Composition in Human Non-small Cell Lung Cancer
Open accessAbstract
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death in the world. Immunological analysis of the tumor microenvironment (immunoscore) shows great promise for improved prognosis and prediction of response to immunotherapy. However, the exact immune cell composition in NSCLC remains unclear. Here, we used flow cytometry to characterize the immune infiltrate in NSCLC tumors, non-cancerous lung tissue, regional lymph node, and blood. The cellular identity of >95% of all CD45+ immune cells was determined. Thirteen distinct immune cell types were identified in NSCLC tumors. T cells dominated the lung cancer landscape (on average 46% of all CD45+ immune cells). CD4+ T cells were the most abundant T cell population (26%), closely followed by CD8+ T cells (19%). Double negative CD4-CD8- T cells represented a small fraction (1.3%). CD19+ B cells were the second most common immune cell type in NSCLC tumors (16%), and four different B cell sub-populations were identified. Macrophages and natural killer (NK) cells composed 5.1% and 4.3% of the immune cell infiltrate, respectively. Three types of dendritic cells (DCs) were identified (plasmacytoid DCs, CD1c+ DCs, and CD141+ DCs) which together represented 1.7% of all immune cells. Among granulocytes, neutrophils were frequent (8.1%) with a high patient-to-patient variability, while mast cells (1.3%), basophils (0.4%), and eosinophils (0.3%) were less common. Across the cohort of patients, only B cells showed a significantly higher representation in NSCLC tumors compared to the distal lung. In contrast, the percentages of macrophages and NK cells were lower in tumors than in non-cancerous lung tissue. Furthermore, the fraction of macrophages with high HLA-DR expression levels was higher in NSCLC tumors relative to distal lung tissue. To make the method readily accessible, antibody panels and flow cytometry gating strategy used to identify the various immune cells are described in detail. This work will represent a useful resource for the immunomonitoring of patients with NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 2×
“Furthermore, although naïve T cells are classically being defined as CD45RACD45RO, it should be noted that CD45RA effector/memory CD8 T cells (the so called TEMRA cells) have been reported (33, 34).”
BackgroundIntratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Brahmer, J. R., Drake, C. G., Wollner, I., Powderly, J. D., Picus, J., Sharfman, W. H., Stankevich, E., Pons, A., Salay, T. M., McMiller, T. L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7609 · Cited by 2,961
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Forde, P. M., Chaft, J. E., Smith, K. N., Anagnostou, V., Cottrell, T. R., Hellmann, M. D., Zahurak, M., Yang, S. C., Jones, D. R., Broderick, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716078 · Cited by 2,099
Non-small-cell lung cancers: a heterogeneous set of diseases
Chen, Z., Fillmore, C. M., Hammerman, P. S., Kim, C. F., & Wong, K.-K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3775 · Cited by 1,942
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S. H., Onai, N., Schraml, B. U., Segura, E., Tussiwand, R., & Yona, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3712 · Cited by 1,819
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Lavin, Y., Kobayashi, S., Leader, A., Amir, E.-A. D., Elefant, N., Bigenwald, C., Remark, R., Sweeney, R., Becker, C. D., Levine, J. H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.014 · Cited by 1,209
CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.
Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H., & Ohtani, H. (1998) · PubMed · Cited by 1,193
Dieu-Nosjean, M.-C., Antoine, M., Danel, C., Heudes, D., Wislez, M., Poulot, V., Rabbe, N., Laurans, L., Tartour, E., de Chaisemartin, L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0284 · Cited by 1,031
Germain, C., Gnjatic, S., Tamzalit, F., Knockaert, S., Remark, R., Goc, J., Lepelley, A., Becht, E., Katsahian, S., Bizouard, G., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1611oc · Cited by 833
Cancer classification using the Immunoscore: a worldwide task force
Galon, J., Pagès, F., Marincola, F. M., Angell, H. K., Thurin, M., Lugli, A., Zlobec, I., Berger, A., Bifulco, C., Botti, G., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-205 · Cited by 791
Haniffa, M., Shin, A., Bigley, V., McGovern, N., Teo, P., See, P., Wasan, P. S., Wang, X.-N., Malinarich, F., Malleret, B., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.012 · Cited by 724
Goldstraw, P., Ball, D., Jett, J. R., Le Chevalier, T., Lim, E., Nicholson, A. G., & Shepherd, F. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62101-0 · Cited by 711
Human Inflammatory Dendritic Cells Induce Th17 Cell Differentiation
Segura, E., Touzot, M., Bohineust, A., Cappuccio, A., Chiocchia, G., Hosmalin, A., Dalod, M., Soumelis, V., & Amigorena, S. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.018 · Cited by 676
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Eruslanov, E. B., Bhojnagarwala, P. S., Quatromoni, J. G., Stephen, T. L., Ranganathan, A., Deshpande, C., Akimova, T., Vachani, A., Litzky, L., Hancock, W. W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77053 · Cited by 644
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
Al-Shibli, K. I., Donnem, T., Al-Saad, S., Persson, M., Bremnes, R. M., & Busund, L.-T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 614
Geginat, J., Lanzavecchia, A., & Sallusto, F. (2003) · Blood · doi:10.1182/blood-2002-11-3577 · Cited by 601
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K., Yatabe, Y., Powell, C. A., Beer, D., Riely, G., Garg, K., et al. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201107-042st · Cited by 586
Recombinant interferon-gamma increases HLA-DR synthesis and expression.
Basham, T. Y., & Merigan, T. C. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1492 · Cited by 575
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
Platonova, S., Cherfils-Vicini, J., Damotte, D., Crozet, L., Vieillard, V., Validire, P., André, P., Dieu-Nosjean, M.-C., Alifano, M., Régnard, J.-F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4179 · Cited by 512
Hiraoka, K., Miyamoto, M., Cho, Y., Suzuoki, M., Oshikiri, T., Nakakubo, Y., Itoh, T., Ohbuchi, T., Kondo, S., & Katoh, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602934 · Cited by 481
Primary Antitumor Immune Response Mediated by CD4+ T Cells
Corthay, A., Skovseth, D. K., Lundin, K. U., Røsjø, E., Omholt, H., Hofgaard, P. O., Haraldsen, G., & Bogen, B. (2005) · Immunity · doi:10.1016/j.immuni.2005.02.003 · Cited by 478
Self-citationSiliņa, K., Soltermann, A., Attar, F. M., Casanova, R., Uckeley, Z. M., Thut, H., Wandres, M., Isajevs, S., Cheng, P., Curioni-Fontecedro, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1987 · Cited by 448
Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer
Schalper, K. A., Brown, J., Carvajal-Hausdorf, D., McLaughlin, J., Velcheti, V., Syrigos, K. N., Herbst, R. S., & Rimm, D. L. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju435 · Cited by 417
Neutrophils dominate the immune cell composition in non-small cell lung cancer
Kargl, J., Busch, S. E., Yang, G. H. Y., Kim, K.-H., Hanke, M. L., Metz, H. E., Hubbard, J. J., Lee, S. M., Madtes, D. K., McIntosh, M. W., et al. (2017) · Nature Communications · doi:10.1038/ncomms14381 · Cited by 412
Carrega, P., Morandi, B., Costa, R., Frumento, G., Forte, G., Altavilla, G., Ratto, G. B., Mingari, M. C., Moretta, L., & Ferlazzo, G. (2008) · Cancer · doi:10.1002/cncr.23239 · Cited by 379
Welsh, T. J., Green, R. H., Richardson, D., Waller, D. A., O'Byrne, K. J., & Bradding, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4910 · Cited by 369
de Chaisemartin, L., Goc, J., Damotte, D., Validire, P., Magdeleinat, P., Alifano, M., Cremer, I., Fridman, W.-H., Sautès-Fridman, C., & Dieu-Nosjean, M.-C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0952 · Cited by 338
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
Haabeth, O. A. W., Lorvik, K. B., Hammarström, C., Donaldson, I. M., Haraldsen, G., Bogen, B., & Corthay, A. (2011) · Nature Communications · doi:10.1038/ncomms1239 · Cited by 318
Self-citationOhri, C. M., Shikotra, A., Green, R. H., Waller, D. A., & Bradding, P. (2009) · European Respiratory Journal · doi:10.1183/09031936.00065708 · Cited by 296
Dendritic Cells Display Subset and Tissue-Specific Maturation Dynamics over Human Life
Granot, T., Senda, T., Carpenter, D. J., Matsuoka, N., Weiner, J., Gordon, C. L., Miron, M., Kumar, B. V., Griesemer, A., Ho, S.-H., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.019 · Cited by 290
The 7th lung cancer TNM classification and staging system: Review of the changes and implications
Mirsadraee, S. (2012) · World Journal of Radiology · doi:10.4329/wjr.v4.i4.128 · Cited by 261
Wakabayashi, O., Yamazaki, K., Oizumi, S., Hommura, F., Kinoshita, I., Ogura, S., Dosaka‐Akita, H., & Nishimura, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01392.x · Cited by 252
Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages
Müller, E., Christopoulos, P. F., Halder, S., Lunde, A., Beraki, K., Speth, M., Øynebråten, I., & Corthay, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01383 · Cited by 239
Self-citationIncreased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients
Chen, X., Wan, J., Liu, J., Xie, W., Diao, X., Xu, J., Zhu, B., & Chen, Z. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.013 · Cited by 217
Huang, A., Zhang, B., Wang, B., Zhang, F., Fan, K.-X., & Guo, Y.-J. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1450-6 · Cited by 210
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
Donnem, T., Kilvaer, T. K., Andersen, S., Richardsen, E., Paulsen, E. E., Hald, S. M., Al-Saad, S., Brustugun, O. T., Helland, A., Lund-Iversen, M., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdv560 · Cited by 187
Self-citationIlie, M., Hofman, V., Ortholan, C., Bonnetaud, C., Coëlle, C., Mouroux, J., & Hofman, P. (2012) · Cancer · doi:10.1002/cncr.26456 · Cited by 179
Kataki, A., Scheid, P., Piet, M., Marie, B., Martinet, N., Martinet, Y., & Vignaud, J.-M. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.128317 · Cited by 166
Ganesan, A.-P., Johansson, M., Ruffell, B., Beltran, A., Lau, J., Jablons, D. M., & Coussens, L. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301317 · Cited by 140
Immune cell infiltrates and prognosis in primary carcinoma of the lung
Johnson, S. K., Kerr, K. M., Chapman, A. D., Kennedy, M. M., King, G., Cockburn, J. S., & Jeffrey, R. R. (2000) · Lung Cancer · doi:10.1016/s0169-5002(99)00095-1 · Cited by 134
Horne, Z. D., Jack, R., Gray, Z. T., Siegfried, J. M., Wilson, D. O., Yousem, S. A., Nason, K. S., Landreneau, R. J., Luketich, J. D., & Schuchert, M. J. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.03.068 · Cited by 133
Multiparametric profiling of non–small-cell lung cancers reveals distinct immunophenotypes
Lizotte, P. H., Ivanova, E. V., Awad, M. M., Jones, R. E., Keogh, L., Liu, H., Dries, R., Almonte, C. G., Herter-Sprie, G. S., Santos, A. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.89014 · Cited by 129
Carus, A., Ladekarl, M. B., Hager, H., Pilegaard, H. K., Nielsen, P. S., & Donskov, F. N. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.03.003 · Cited by 128
Rajagopal, D., Paturel, C., Morel, Y., Uematsu, S., Akira, S., & Diebold, S. S. (2010) · Blood · doi:10.1182/blood-2009-08-238543 · Cited by 122
Müller, E., Speth, M. T., CHRISTOPOULOS, P. F., Lunde, A., Avdagic, A., Øynebråten, I., & Corthay, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02520 · Cited by 120
Self-citationDomagala-Kulawik, J. J. (2015) · PubMed · doi:10.3978/j.issn.2218-6751.2015.01.11 · Cited by 118
Immune and inflammatory cell composition of human lung cancer stroma
Banat, G.-A., Tretyn, A., Pullamsetti, S. S., Wilhelm, J., Weigert, A., Olesch, C., Ebel, K., Stiewe, T., Grimminger, F., Seeger, W., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139073 · Cited by 107
Al-Shibli, K. I., Al‐Saad, S., Dønnem, T., Persson, M., Bremnes, R. M., & Busund, L. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03379.x · Cited by 103
Kilic, A., Landreneau, R. J., Luketich, J. D., Pennathur, A., & Schuchert, M. J. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.08.029 · Cited by 95
Zocchi, M. R., Ferrarini, M., & Rugarli, C. (1990) · European Journal of Immunology · doi:10.1002/eji.1830201224 · Cited by 90
Chapter 5 Human B Cell Subsets
Jackson, S. M., Wilson, P. C., James, J. A., & Capra, J. D. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00405-7 · Cited by 88
Clavarino, G., Delouche, N., Vettier, C., Laurin, D., Pernollet, M., Raskovalova, T., Cesbron, J.-Y., Dumestre‐Pérard, C., & Jacob, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162209 · Cited by 58
Richter, L., Landsverk, O. J. B., Atlasy, N., Bujko, A., Yaqub, S., Horneland, R., Øyen, O. M., Aandahl, E. M., Lundin, K. E. A., Stunnenberg, H. G., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0060-1 · Cited by 46
Self-citationRecent developments in the use of immunotherapy in non-small cell lung cancer
Santarpía, M., Giovannetti, E., Rolfo, C. D., Karachaliou, N., González‐Cao, M., Altavilla, G., & Rosell, R. (2016) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2016.1182866 · Cited by 28
Rituximab efficiently depletes B cells in lung tumors and normal lung tissue
Joly-Battaglini, A., Hammarström, C. L., Stankovic, B., Aamodt, H., Stjärne, J., Brustugun, O. T., Helland, Å., Øynebråten, I., & Corthay, A. (2016) · F1000Research · doi:10.12688/f1000research.7599.1 · Cited by 17
Self-citationCorthay, A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-34814-8_14 · Cited by 15
Self-citationCD56+-T-Cell Responses to Bacterial Superantigens and Immune Recognition of Attenuated Vaccines
Saikh, K. U., Dyas, B. K., Kissner, T. L., & Ulrich, R. G. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.6.1065-1073.2003 · Cited by 10
A large fraction of human tonsillar B cells expressing CD27 are germinal center B cells
Przekopowitz, M., Küppers, R., & Weniger, M. A. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.6 · Cited by 6
Cited by
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
Salcher, S., Sturm, G., Horvath, L., Untergasser, G., Kuempers, C., Fotakis, G., Panizzolo, E., Martowicz, A., Trebo, M., Pall, G., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.10.008 · Cited by 477
Tumor-Infiltrating Natural Killer Cells
Cózar, B., Greppi, M., Carpentier, S., Narni-Mancinelli, E., Chiossone, L., & Vivier, E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0655 · Cited by 476
Dendritic cell subsets and locations
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.07.004 · Cited by 349
Sun, J., Zhang, Z., Bao, S., Yan, C., Hou, P., Wu, N., Su, J., Xu, L., & Zhou, M. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000110 · Cited by 291
Metadata
- Authors
- Stankovic, B., Bjørhovde, H. A. K., Skarshaug, R., Aamodt, H., Frafjord, A., Müller, E., Hammarström, C., Beraki, K., Bækkevold, E. S., Woldbæk, P. R., Helland, Å., Brustugun, O. T., Øynebråten, I., & Corthay, A.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-02-01
- Volume
- 9
- Pages
- 3101-3101
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2913543249
- Cited by
- 341
- References
- 65
- FWCI
- 15.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.